Drug consumption rooms to reduce HIV and HCV | www.emcdda.europa.eu

Best practice portal main page

Summary of the evidence

Rating

Unknown effectiveness

A review of reviews (MacArthur et al., 2014, N=25 reviews), without meta-analysis, concluded that there is:

insufficient evidence to support the effectiveness of drug consumption rooms in reducing HIV infections (N=1 study, 1 no association)
insufficient evidence to support the effectiveness of drug consumption rooms in reducing HCV infections (N=1 study, 1 no association)

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option

Drug consumption rooms (DCRs)

Desired outcome(s)

reduce infectious diseases

Area(s)

Harm reduction

Specific substance or pattern of use

amphetamines
opioids

Target group(s) or setting(s)

PWID – people who inject drugs

References

MacArthur, G. J., et al (2014),Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. International Journal of Drug Policy (2014)

Explore all resources in the Best practice portal

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

Evidence

All of the latest research and evidence on drug-related interventions.

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice